Showing 4 of 4 recruiting trials for “Plasmacytoma”
Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration
SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial
🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Feb 2025View details ↗
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →